Menu
Washingtoner
  • Home
  • Business
  • Construction
  • Transportation
  • Aerospace
  • Boeing
  • Kelly Ortberg
  • Manufacturing
  • Crypto
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • ExtraCarry Now Supports Taurus GX2 13-Round Mags and 15-Round Magazines
  • Award-Winning Author Zane Carson Carruth Featured in USA Today for Inspiring Mission to Nurture Young Hearts Through Storytelling
  • Oom Yung Doe Hosts Children's Halloween Safety Seminar in Kirkland
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • NFL Midseason 2025: Who's for Real and Who's Faking It?
  • City of Tacoma Investing in New Technology to Enhance Customer Service
  • Silver Ball, Golden Heart: Dallas-Area Pinball Wizards Flip for Charity at Side Quest Arcade
  • Sweet Beginnings: Sugar Queen Dessert Shop Opens in the Colony Ridge Community
  • Spokane: Council Community Days in Honor of Veterans Day

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Pioneering the Future of Human-Computer Interaction Through AI-Powered Neural Input Technology: Wearable Devices Ltd. (N A S D A Q: WLDS)
  • Epic Pictures Group Sets North American Release Date for the Action Thriller LOST HORIZON
  • HR Soul Consulting Recognized as a 2025 Inc. Power Partner Award Winner for the Fourth Consecutive Year
  • Eramls Investment Alliance under Nolan Mercer Launches InsightNova System for AI-Driven Investing
  • Pullman Good Food Co-op Announces Future Home in the Heart of Downtown Pullman
  • Atrish Investment Alliance Under Asher Mercer Expands Global Compliance Collaboration
  • Spokane: Hope Soccer and Parks and Rec Partner to Expand Youth Soccer Access
  • Tacoma: Portion of McMurray Hill Road NE to Close for Hazardous Tree Removal
  • Tacoma: Connect With Creativity at 'Arts at the Armory' on November 15 and 16
  • Spokane: City Details Veterans Day Schedule
  • Brazil 021 Chicago Launches New Website and Expands with No-Gi Classes for All Levels
  • American Star Guard Unveils a Powerful Rebrand and Expanded Security Services Throughout Nevada
  • PlaceBased Media Expands Point-of-Care Advertising Inventory Across U.S. Clinic Network
  • Flexible Plan Investments launches FlexDirex, a first-to-market suite of single-stock ETF strategies in the U.S
  • Spokane: Mayor Brown Introduces Mid-Biennium Budget Modification To Close Deficit While Maintaining Community Priorities
  • Spokane Police Chief's statement
  • Spokane: Council Member Bingle to Host Press Conference
  • Tacoma: Registration Now Open for OMWBE Active Certification Class on November 17
  • Global Trade: The Pathway to Economic Prosperity
  • Revenue Optics Ignites AI Revolution in Industrial Distribution
_catLbl0 _catLbl1

Popular on Washingtoner

  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks
  • Rep. Gina H. Curry and Dr. Conan Tu Inspire at Kopp Foundation for Diabetes Hybrid Fundraising Gala and National Leadership Forum
  • Spokane: City Construction Projects Traffic Impacts Next Week
  • Jaipur's Savista Retreat announces $299 all-inclusive nightly rate for two for the 2026 season, including meals and city-center transfers
  • Cancer Survivor Roslyn Franken Marks 30-Year Milestone with Empowering Gift for Women Survivors
  • City of Spokane Announces Next Chapter of HOME Starts Here Initiative
  • New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
  • GlobalBoost Announces Listing on Biconomy Exchange Expanding Accessibility of Decentralized Payments
  • Some Music for Donald's Bad Day
  • ExtraCarry Now Supports Taurus GX2 13-Round Mags and 15-Round Magazines

Similar on Washingtoner

  • Passion Struck Network Debuts: A Creator-First Platform for Purpose-Driven Podcasting and Human Impact
  • The Aligned Woman Is It Well With Your Soul
  • Silver Ball, Golden Heart: Dallas-Area Pinball Wizards Flip for Charity at Side Quest Arcade
  • Pioneering the Future of Human-Computer Interaction Through AI-Powered Neural Input Technology: Wearable Devices Ltd. (N A S D A Q: WLDS)
  • PlaceBased Media Expands Point-of-Care Advertising Inventory Across U.S. Clinic Network
  • CCHR Exposes Harms Behind Today's Mental Health Awareness Campaigns
  • Veterans Day 2025: Virginia Veterans Can Claim Free Words of Veterans Book Vouchers
  • Parkchester Oral & Maxillofacial Surgery Celebrates 450+ 5-Star Reviews
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer
  • Year-Round Deals for Customers With Square Signs
Copyright © 2025 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute